Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 15 crawled time : 23:00 save search
IceCure Medical Reports Financial Results for the First Half of 2022 and Recent Operational Highlights
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: 0.42%
H: 0.3%
C: 0.3%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: 1.52%
H: 0.0%
C: -1.69%
ICCM | $1.23 -4.03% 120K
|
Manufacturing
|
| O: 3.63%
H: 5.0%
C: 1.5%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.27%
H: 0.98%
C: 0.68%
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -1.17%
H: 1.97%
C: -3.35%
FBRX 4 | $0.78 5.13% 8.3K
|
Health Technology
|
| O: -2.26%
H: 0.77%
C: 0.0%
update results
Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
HRMY | $29.42 1.34% 1.33% 390K
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -2.53%
ALRN | $4.785 -4.3% -4.49% 85K
|
Health Technology
|
| O: -2.64%
H: 5.72%
C: 3.63%
therapeutics results
Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
CRON | News | $2.37 -1.66% -1.69% 3.9M
|
Process Industries
|
| O: -0.63%
H: 7.94%
C: 7.94%
results
Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
VTYX | News | $4.47 2.76% 2.68% 910K
|
Manufacturing
|
| O: 0.33%
H: 2.92%
C: 1.53%
results
aTyr Pharma Announces Second Quarter 2022 Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.13%
H: 4.57%
C: 4.0%
pharma update results
Ventyx Biosciences Announces Positive Topline Phase 1 Data for Its Selective Allosteric TYK2 Inhibitor VTX958
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
VTYX | News | $4.47 2.76% 2.68% 910K
|
Manufacturing
|
| O: 0.33%
H: 2.92%
C: 1.53%
vtx958 topline positive phase 1
Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: -0.28%
H: 4.17%
C: 4.02%
results
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
NDRA | $0.2334 1.11% 68K
|
Health Technology
|
| O: 0.0%
H: 5.08%
C: 2.53%
sciences life update results
Panbela Provides Business Update and Reports Q2 2022 Financial Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 0.05%
H: 0.0%
C: -7.75%
update results
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2022 and Business Highlights
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
ABOS | $3.14 -0.63% -0.64% 310K
|
Professional, Scientific, and T...
|
| O: 0.19%
H: 1.85%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.37%
H: 1.75%
C: 1.53%
Ayala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: -0.74%
H: 2.96%
C: -7.41%
update results
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
monkeypox device global test health
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
RVPH | $3.035 0.5% 0.49% 140K
|
|
| O: 0.0%
H: 18.31%
C: 15.49%
results
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.28%
H: 0.19%
C: -0.44%
results
Arcellx Provides Business Highlights and Reports Second Quarter 2022 Financial Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
ACLX | $51.67 -5.19% -5.48% 740K
|
|
| O: 0.0%
H: 3.72%
C: 3.72%
results
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.12%
C: -0.57%
XCUR 4 | $0.5825 0.64% 0.64% 22K
|
Commercial Services
|
| O: -0.44%
H: 5.29%
C: 2.2%
results
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -0.35%
H: 3.56%
C: 3.0%
results
NexImmune Reports Second Quarter 2022 Financial Results and Highlights FDA Clearance of IND for NEXI-003 for the Treatment of HPV-Related Cancers
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
NEXI | $3.22 -2.42% -2.48% 23K
|
|
| O: 0.76%
H: 0.76%
C: -4.55%
nexi-003 treatment fda clearance
European Medicines Agency Grants Orphan Drug Designation to INBRX-109 for the Treatment of Chondrosarcoma
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
INBX | $34.36 -0.26% -0.26% 220K
|
Health Technology
|
| O: -1.64%
H: 3.03%
C: 2.58%
inbrx-109 treatment designation drug grants
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.